Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

BACKGROUND: Brimonidine tartrate is a highly selective alpha 2 agonist that induces direct vasoconstriction of small arteries and veins, thereby reducing vasodilation and edema. OBJECTIVE: To review the current literature regarding the safety, efficacy, and patient acceptability of brimonidine 0.33%...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Patient Prefer Adherence
Autores principales: Anderson, Michael S, Nadkarni, Anish, Cardwell, Leah A, Alinia, Hossein, Feldman, Steven R
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5505675/
https://ncbi.nlm.nih.gov/pubmed/28740369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S115708
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares